Oncology Today with Dr Neil Love cover image

Management of HER2-Altered Non-Small Cell Lung Cancer

Oncology Today with Dr Neil Love

00:00

Drug Development Pathways for ADCs

There are two drug development pathways for ADCs. One is the precision pathway, which is personally my preferred way of developing drugs. The HER2 Newton story is the prototype for that. And I hope to develop more for HER2 amplification and many other targets down the track. But certainly, I'm hoping for a more precision drug development pathway.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app